Page last updated: 2024-11-08

biguanides and Leukemia, Myeloid, Acute

biguanides has been researched along with Leukemia, Myeloid, Acute in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spiers, AS1
Tattersall, MH1
Gaya, H1
Langslet, A1
Olsen, I1
Lie, SO1
Lokken, P1

Other Studies

2 other studies available for biguanides and Leukemia, Myeloid, Acute

ArticleYear
Indications for systemic antibiotic prophylaxis in neutropenic patients.
    British medical journal, 1974, Nov-23, Volume: 4, Issue:5942

    Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Biguanides; Blood Cell Count; Carbenicillin; Cephalot

1974
Chlorhexidine treatment of oral candidiasis in seriously diseased children.
    Acta paediatrica Scandinavica, 1974, Volume: 63, Issue:6

    Topics: Administration, Topical; Adolescent; Biguanides; Candidiasis, Oral; Child; Child, Preschool; Chronic

1974